Cognitive testing in early-phase clinical trials: Development of a rapid computerized test battery and application in a simulated Phase I study

Contemporary Clinical Trials - Tập 28 - Trang 391-400 - 2007
Alex Collie1,2, Amanda Darekar3, Georges Weissgerber4, Melvin K. Toh5, Peter J. Snyder6, Paul Maruff1,7, John P. Huggins3
1Cogstate Ltd., Melbourne, Australia
2Centre for Neuroscience, The University of Melbourne, Australia
3Pfizer Global Research and Development, Sandwich, United Kingdom CT13 9NJ
4Pfizer Clinical Research Unit, Erasme, Hôpital Erasme, Route de Lennik, 808, B-1070 Brussels, Belgium
5Pfizer Global Research and Development, 11095 Torreyana Rd, San Diego, CA 92121, USA
6Department of Psychology, The University of Conneticut, USA
7Department of Psychology, La Trobe University, Melbourne, Australia

Tài liệu tham khảo

Beglinger, 2005, Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study, J Clin Psychopharmacol, 25, 159, 10.1097/01.jcp.0000155822.51962.b4

Beglinger, 2004, Neuropsychological test performance in healthy volunteers before and after donepezil administration, J Psychopharmacol, 18, 102, 10.1177/0269881104040248

Meyers, 2000, Cognitive function as a predictor of survival in patients with recurrent malignant glioma, J Clin Oncol, 18, 646, 10.1200/JCO.2000.18.3.646

van der Meyden, 1992, Effect of acute doses of controlled-release carbamazepine on clinical, psychomotor, electrophysiological, and cognitive parameters of brain function, Epilepsia, 33, 335, 10.1111/j.1528-1157.1992.tb02324.x

Collie, 2003, The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test–retest intervals, J Int Neuropsychol Soc, 9, 419, 10.1017/S1355617703930074

Mollica, 2004, Development of a statistical approach to classifying treatment response in individual children with ADHD, Hum Psychopharm, 19, 445, 10.1002/hup.624

Beglinger, 2005, Practice effects and the use of alternate forms in serial neuropsychological testing, Arch Clin Neuropsychol, 20, 517, 10.1016/j.acn.2004.12.003

Rogers, 2002, Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics, Clin Pharmacol Ther, 72, 711, 10.1067/mcp.2002.128866

Thompson, 1999, Cognitive properties of sedation agents: comparison of the effects of nitrous oxide and midazolam on memory and mood, Br Dent J, 187, 557, 10.1038/sj.bdj.4800330

Marshall, 2000, Pediatric pharmacodynamics of midazolam oral syrup. Pediatric Pharmacology Research Unit Network, J Clin Pharmacol, 40, 578, 10.1177/00912700022009350

Falleti, 2003, Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%, J Sleep Res, 12, 265, 10.1111/j.1365-2869.2003.00363.x

Barker, 1931, The stepping-stone maze: a directly visible space-problem apparatus, J Gen Psychol, 5, 280, 10.1080/00221309.1931.9918402

Kanto, 1985, Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia, Pharmacotherapy, 5, 138, 10.1002/j.1875-9114.1985.tb03411.x

Ibrahim, 2001, Speed of recovery and side-effect profile of sevoflurane sedation compared with midazolam, Anesthesiology, 94, 87, 10.1097/00000542-200101000-00018

Girdler, 2002, A randomized, controlled trial of cognitive and psychomotor recovery from midazolam sedation following reversal with oral flumazenil, Anaesthesia, 57, 868, 10.1046/j.1365-2044.2002.02785.x

Hirshman, 2003, Midazolam amnesia and retrieval from semantic memory: developing methods to test theories of implicit memory, Brain Cog, 53, 427, 10.1016/S0278-2626(03)00214-8

Collie, 2004, Baseline CogSport performance in elite and non-elite athletes: an international study, Br J Sports Med, 38, 655